威尔药业(603351)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

603351 威尔药业

已收盘 03-09 15:00:00

{"stockData":{"symbol":"603351","market":"SH","secType":"STK","nameCN":"威尔药业","latestPrice":26.14,"timestamp":1773039601000,"preClose":26.57,"halted":0,"volume":676320,"delay":0,"changeRate":-0.0162,"floatShares":135000000,"shares":135000000,"eps":1.0898,"marketStatus":"已收盘","change":-0.43,"latestTime":"03-09 15:00:00","open":26.33,"high":26.51,"low":25.77,"amount":17659800,"amplitude":0.0279,"askPrice":26.14,"askSize":3,"bidPrice":26.08,"bidSize":6,"shortable":0,"etf":0,"ttmEps":1.0898,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1773106200000},"marketStatusCode":5,"adr":0,"adjPreClose":26.57,"symbolType":"stock","openAndCloseTimeList":[[1773019800000,1773027000000],[1773032400000,1773039600000]],"highLimit":29.23,"lowLimit":23.91,"ibTradeSell":true,"ibTradeBuySell":false,"totalEquity":135439132,"isCdr":false,"pbRate":2.01,"roa":"--","peRate":23.986052,"roe":"6.55%","epsLYR":1.08,"committee":0.440678,"marketValue":3540000000,"turnoverRate":0.005,"status":1,"floatMarketCap":3540000000},"requestUrl":"/m/hq/s/603351/wiki","defaultTab":"wiki","newsList":[{"id":"2616845411","title":"每周股票复盘：威尔药业（603351）股东拟减持不超0.33%股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2616845411","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616845411?lang=zh_cn&edition=full","pubTime":"2026-03-01 03:00","pubTimestamp":1772305238,"startTime":"0","endTime":"0","summary":"截至2026年2月27日收盘，威尔药业报收于27.29元，较上周的27.08元上涨0.78%。本周，威尔药业2月25日盘中最高价报28.0元。威尔药业当前最新总市值36.96亿元，在化学制药板块市值排名126/150，在两市A股市值排名4330/5189。该股东拟于2026年3月23日至4月10日通过集中竞价交易方式减持不超过446,340股，即不超过公司总股本的0.33%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026030100001129.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0275","BK0239","603351"],"gpt_icon":0},{"id":"2614011868","title":"威尔药业最新公告：股东舜泰宗华拟减持不超0.33%股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2614011868","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614011868?lang=zh_cn&edition=full","pubTime":"2026-02-26 17:41","pubTimestamp":1772098860,"startTime":"0","endTime":"0","summary":"威尔药业(603351.SH)公告称，股东南京舜泰宗华创业投资合伙企业（有限合伙）拟自2026年3月23日至4月10日期间，通过集中竞价交易方式减持公司股份不超过446,340股，即不超过公司总股本的0.33%；减持原因为股东资金需求；股份来源为首次公开发行前持有及上市后资本公积转增股本取得。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026022600028095.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","603351","BK0275"],"gpt_icon":0},{"id":"2588884838","title":"威尔药业（603351）披露关于完成工商备案登记的公告，12月4日股价下跌1.54%","url":"https://stock-news.laohu8.com/highlight/detail?id=2588884838","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588884838?lang=zh_cn&edition=full","pubTime":"2025-12-04 22:30","pubTimestamp":1764858645,"startTime":"0","endTime":"0","summary":"截至2025年12月4日收盘，威尔药业报收于26.84元，较前一交易日下跌1.54%，最新总市值为36.35亿元。该股当日开盘27.11元，最高27.2元，最低26.4元，成交额达3017.34万元，换手率为0.83%。近日，威尔药业发布关于完成工商备案登记的公告。公告显示，南京威尔药业集团股份有限公司于2025年10月29日召开第三届董事会第十三次会议，并于2025年11月14日召开2025年第一次临时股东大会，审议通过取消监事会并修订《公司章程》的议案。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025120400039802.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0275","603351"],"gpt_icon":0},{"id":"2583651544","title":"每周股票复盘：威尔药业（603351）取消监事会获股东会通过","url":"https://stock-news.laohu8.com/highlight/detail?id=2583651544","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2583651544?lang=zh_cn&edition=full","pubTime":"2025-11-16 03:26","pubTimestamp":1763234774,"startTime":"0","endTime":"0","summary":"截至2025年11月14日收盘，威尔药业报收于30.12元，较上周的28.71元上涨4.91%。本周关注点公司公告汇总：威尔药业股东大会通过取消监事会并修订公司章程的议案。南京威尔药业集团股份有限公司于2025年11月14日召开2025年第一次临时股东大会，会议由董事会召集，吴仁荣主持，采用现场与网络投票结合方式举行。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025111600000814.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603351","BK0275","BK0239"],"gpt_icon":0},{"id":"2582861036","title":"每周股票复盘：威尔药业（603351）拟取消监事会","url":"https://stock-news.laohu8.com/highlight/detail?id=2582861036","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2582861036?lang=zh_cn&edition=full","pubTime":"2025-11-09 04:25","pubTimestamp":1762633512,"startTime":"0","endTime":"0","summary":"截至2025年11月7日收盘，威尔药业报收于28.71元，较上周的28.92元下跌0.73%。本周，威尔药业11月7日盘中最高价报29.17元。本周关注点公司公告汇总：威尔药业拟取消监事会，由董事会审计委员会行使监事会职权。公司公告汇总威尔药业2025年第一次临时股东大会会议资料南京威尔药业集团股份有限公司拟取消监事会，不再设监事，由董事会审计委员会行使监事会职权，并废止《监事会议事规则》。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025110900001588.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603351","BK0239","BK0275"],"gpt_icon":0},{"id":"2581509456","title":"威尔药业（603351）披露拟取消监事会并由董事会审计委员会行使监事会职权，11月06日股价上涨1.3%","url":"https://stock-news.laohu8.com/highlight/detail?id=2581509456","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2581509456?lang=zh_cn&edition=full","pubTime":"2025-11-06 22:33","pubTimestamp":1762439604,"startTime":"0","endTime":"0","summary":"截至2025年11月6日收盘，威尔药业报收于28.84元，较前一交易日上涨1.3%，最新总市值为39.06亿元。根据近日发布的《威尔药业2025年第一次临时股东大会会议资料》，南京威尔药业集团股份有限公司拟取消监事会，不再设监事，由董事会审计委员会行使监事会职权，并废止《监事会议事规则》。此外，公司还计划修订股东会议事规则、董事会议事规则、独立董事工作制度等多项治理制度，部分制度修订尚需提交股东大会审议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025110600038379.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0275","603351"],"gpt_icon":0},{"id":"2580423470","title":"每周股票复盘：威尔药业（603351）Q3净利增21.46%","url":"https://stock-news.laohu8.com/highlight/detail?id=2580423470","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2580423470?lang=zh_cn&edition=full","pubTime":"2025-11-02 08:19","pubTimestamp":1762042755,"startTime":"0","endTime":"0","summary":"截至2025年10月31日收盘，威尔药业报收于28.92元，较上周的27.43元上涨5.43%。股本股东变化截至2025年9月30日，威尔药业股东户数为6776户，较6月30日增加345户，增幅5.36%。业绩披露要点威尔药业2025年三季报显示，前三季度主营收入10.18亿元，同比上升1.79%；归母净利润1.14亿元，同比上升1.03%；扣非净利润1.1亿元，同比上升6.97%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025110200001821.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0275","603351"],"gpt_icon":0},{"id":"2579190073","title":"威尔药业(603351)9月30日股东户数0.68万户，较上期增加5.36%","url":"https://stock-news.laohu8.com/highlight/detail?id=2579190073","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2579190073?lang=zh_cn&edition=full","pubTime":"2025-10-30 17:21","pubTimestamp":1761816118,"startTime":"0","endTime":"0","summary":"证券之星消息，近日威尔药业披露，截至2025年9月30日公司股东户数为6776.0户，较6月30日增加345.0户，增幅为5.36%。在化学制药行业个股中，威尔药业股东户数低于行业平均水平，截至9月30日，化学制药行业平均股东户数为3.43万户。从股价来看，2025年6月30日至2025年9月30日，威尔药业区间涨幅为2.61%，在此期间股东户数增加345.0户，增幅为5.36%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025103000032677.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","603351","BK0275"],"gpt_icon":0},{"id":"2579707609","title":"图解威尔药业三季报：第三季度单季净利润同比增长21.46%","url":"https://stock-news.laohu8.com/highlight/detail?id=2579707609","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2579707609?lang=zh_cn&edition=full","pubTime":"2025-10-29 19:46","pubTimestamp":1761738362,"startTime":"0","endTime":"0","summary":"证券之星消息，威尔药业2025年三季报显示，前三季度公司主营收入10.18亿元，同比上升1.79%；归母净利润1.14亿元，同比上升1.03%；扣非净利润1.1亿元，同比上升6.97%；其中2025年第三季度，公司单季度主营收入3.45亿元，同比上升10.35%；单季度归母净利润4129.86万元，同比上升21.46%；单季度扣非净利润3822.07万元，同比上升12.8%；负债率31.69%，投资收益1.54万元，财务费用793.74万元，毛利率28.48%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102900040530.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603351"],"gpt_icon":0},{"id":"2578500455","title":"每周股票复盘：威尔药业（603351）股东减持135.43万股占总股本0.9999%","url":"https://stock-news.laohu8.com/highlight/detail?id=2578500455","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2578500455?lang=zh_cn&edition=full","pubTime":"2025-10-26 04:43","pubTimestamp":1761424987,"startTime":"0","endTime":"0","summary":"截至2025年10月24日收盘，威尔药业报收于27.43元，较上周的28.08元下跌2.31%。该股东为公司员工持股平台，减持前持股7.49%。当前持股数量为8,788,699股，占总股本6.49%。威尔药业关于持股5%以上股东权益变动触及1%刻度的提示性公告南京威尔药业集团股份有限公司公告，信息披露义务人南京舜泰宗华创业投资合伙企业及其一致行动人吴仁荣、高正松、陈新国在2025年8月20日至10月22日期间，通过集中竞价减持公司股份1,354,291股，占总股本1%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102600001304.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","603351","BK0275"],"gpt_icon":0},{"id":"2577585633","title":"威尔药业（603351）披露股东集中竞价减持股份结果公告，10月23日股价下跌0.33%","url":"https://stock-news.laohu8.com/highlight/detail?id=2577585633","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2577585633?lang=zh_cn&edition=full","pubTime":"2025-10-23 22:37","pubTimestamp":1761230230,"startTime":"0","endTime":"0","summary":"近日，南京威尔药业集团股份有限公司发布股东集中竞价减持股份结果公告。股东南京舜泰宗华创业投资合伙企业为公司员工持股平台，减持前持有公司股份10,142,990股，占总股本的7.49%。原计划自2025年8月20日至11月17日通过集中竞价方式减持不超过1,354,390股。截至公告日，舜泰宗华已实际减持1,354,291股，减持价格区间为26.62～31.32元/股，减持总金额38,184,450.82元，当前持股数量为8,788,699股，占总股本的6.49%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102300037939.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603351","BK0239","BK0275"],"gpt_icon":0},{"id":"2516647255","title":"【量价齐升榜前十：梅安森连续5天放量上涨，累计涨幅29.53%】截至3月4日收盘，梅安森量价齐升，连续5天放量上涨，累计涨幅29.53%。其余量价齐升的上涨个股还包括：赛意信息（放量上涨5天）、湖南黄金（放量上涨4天）、华钰矿业（放量上涨4天）、丰山集团（放量上涨4天）、光华股份（放量上涨3天）、梦网科技（放量上涨3天）、旋极信息（放量上涨3天）、华锡有色（放量上涨3天）、威尔药业（放量上涨3天）。","url":"https://stock-news.laohu8.com/highlight/detail?id=2516647255","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516647255?lang=zh_cn&edition=full","pubTime":"2025-03-04 16:46","pubTimestamp":1741077961,"startTime":"0","endTime":"0","summary":"截至3月4日收盘，梅安森量价齐升，连续5天放量上涨，累计涨幅29.53%。其余量价齐升的上涨个股还包括：赛意信息（放量上涨5天）、湖南黄金（放量上涨4天）、华钰矿业（放量上涨4天）、丰山集团（放量上涨4天）、光华股份（放量上涨3天）、梦网科技（放量上涨3天）、旋极信息（放量上涨3天）、华锡有色（放量上涨3天）、威尔药业（放量上涨3天）。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/03/04164648509885.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["SG9999001069.SGD","001333","BK0182","BK0043","SG9999001051.SGD","BK0177","SG9999003461.SGD","002155","300324","BK0275","SG9999001093.SGD","603351","002123","BK0077","BK0127","600301","BK0032","BK0242","BK0004","601020","BK0231","BK0121","BK0070","BK0071","BK0239","BK0037","BK0229","300275","603810","BK0028","BK0090","SG9999002950.SGD","300687"],"gpt_icon":0},{"id":"2514021050","title":"威尔药业02月26日主力净流入0万元 散户资金抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2514021050","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514021050?lang=zh_cn&edition=full","pubTime":"2025-02-26 15:19","pubTimestamp":1740554345,"startTime":"0","endTime":"0","summary":"02月26日, 威尔药业股价涨0.40%，报收25.34元，成交金额1434万元，换手率0.42%，振幅2.73%，量比0.67。该股近5个交易日上涨2.76%，主力资金累计净流出46万元；近20日主力资金累计净流入614万元，其中净流入天数为12日。|02月26日主力加仓幅度前10个股||#|股票简称|主力净额占比|#|科创信息|5.64%|#|夏厦精密|5.19%|#|创世纪|5.07%|#|日科化学|4.54%|#|榕基软件|4.51%|#|山子高科|4.43%|#|恒为科技|3.41%|#|横河精密|3.40%|#|灿芯股份|3.34%|#|日发精机|3.29%|威尔药业所在的化学制药行业，今日主力净流入2.20亿元，行业排名27/124。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226154155abdd7904&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226154155abdd7904&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["603351","BK0239","BK0275"],"gpt_icon":0},{"id":"2512212496","title":"AI+医疗行业深度：AI+医药：势不可挡，未来已至","url":"https://stock-news.laohu8.com/highlight/detail?id=2512212496","media":"中邮证券","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512212496?lang=zh_cn&edition=full","pubTime":"2025-02-19 15:04","pubTimestamp":1739948697,"startTime":"0","endTime":"0","summary":"投资要点“AI+医疗”解决方案全球市场有望突破千亿美元，有望进入到商业化加速阶段。“AI+医疗”行业人工智能解决方案的全球市场规模预计将由2022年的137亿美元增至2030年的1,553亿美元，CAGR为35.5%，行业存在爆发式增长机会。政策面上，国内宏观政策利好AI制药，医疗AI三类证审批加速。我们认为“AI+医疗”有望应用于药物研发、癌症诊断、医学影像、手术机器人等领域，行业或迎来巨变。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250219150422a24b831f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250219150422a24b831f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688189","600521","688062","688428","603207","600664","603229","605507","688247","603520","605177","605116","688235","688166","688266","600851","603811","600513","688658","688799","BK0239","688373","600789","603676","600624","603367","688505","688553","688566","688197","688176","688192","603168","600216","688690","BK0010","BK0175","688602","603669","BK0185","688578","600200","159891","600774","603538","601089","688321","BK0028","600380","600276","600613","688091","688356","600062","688513","600079","600812","688758","688117","688382","688302","688076","600488","159938","BK0188","603351","688221","600196","600420"],"gpt_icon":0},{"id":"2512357421","title":"威尔药业02月18日主力资金流入83万元 连续5日加仓","url":"https://stock-news.laohu8.com/highlight/detail?id=2512357421","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512357421?lang=zh_cn&edition=full","pubTime":"2025-02-18 15:21","pubTimestamp":1739863307,"startTime":"0","endTime":"0","summary":"02月18日, 威尔药业股价跌0.20%，报收24.56元，成交金额1529万元，换手率0.46%，振幅2.68%，量比1.32。威尔药业今日主力资金净流入83万元，连续5日净流入，上一交易日主力净流入74万元。近一年数据显示，该股主力连续5日净流入后，次日上涨概率为60.00%，平均涨幅为1.06%。该股近5个交易日上涨2.04%，主力资金累计净流入649万元，其中2个交易日为股价下跌时净流入；近20日主力资金累计净流入1015万元，其中净流入天数为14日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250218154149abd341cf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250218154149abd341cf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0275","603351","BK0239"],"gpt_icon":0},{"id":"2512130864","title":"威尔药业：药用辅料和润滑油基础油齐头并进 公司进入发展新阶段","url":"https://stock-news.laohu8.com/highlight/detail?id=2512130864","media":"申万宏源研究","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512130864?lang=zh_cn&edition=full","pubTime":"2025-02-18 00:00","pubTimestamp":1739808000,"startTime":"0","endTime":"0","summary":"威尔药业成立于2000 年，2019 年成功上市。公司专注于研发生产药用辅料及合成润滑基础油产品。一致性评价加速产业升级，高端药辅放量增厚公司利润。设备更新换代带动润滑油基础油销售。我们预计公司2024~2026 年实现归母净利润1.5/1.9/2.4 亿元，当前股价对应PE 分别为23x/18x/14x。采用可比公司市盈率估值法，可比公司2025 年对应平均PE 为23x，公司当前市值较可比公司有26%的上涨空间，目标市值为42 亿元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250218182123abd37182&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250218182123abd37182&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0275","603351","BK0239"],"gpt_icon":0},{"id":"2511592277","title":"威尔药业02月13日获主力加仓378万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2511592277","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2511592277?lang=zh_cn&edition=full","pubTime":"2025-02-13 15:20","pubTimestamp":1739431238,"startTime":"0","endTime":"0","summary":"02月13日, 威尔药业股价涨0.12%，报收24.04元，成交金额1715万元，换手率0.53%，振幅3.62%，量比1.86。威尔药业今日主力资金净流入378万元，上一交易日主力净流入28万元。|02月13日主力加仓幅度前10个股||#|股票简称|主力净额占比|#|福石控股|6.29%|#|瑞泰新材|5.57%|#|卓翼科技|5.54%|#|日海智能|5.06%|#|岭南股份|4.51%|#|粤桂股份|4.00%|#|宁波建工|3.93%|#|美邦服饰|3.90%|#|大业股份|3.60%|#|首都在线|3.59%|威尔药业所在的化学制药行业，今日主力净流入635万元，行业排名47/124。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250213153801abcd4b37&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250213153801abcd4b37&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0275","603351","BK0239"],"gpt_icon":0},{"id":"2510827757","title":"医药行业：从摩根大通医疗健康大会看生物创新药管线，关注ADC、双特异性抗体、细胞与基因治疗","url":"https://stock-news.laohu8.com/highlight/detail?id=2510827757","media":"研报虎","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2510827757?lang=zh_cn&edition=full","pubTime":"2025-02-11 13:59","pubTimestamp":1739253565,"startTime":"0","endTime":"0","summary":"2025年第四十三届摩根大通医疗健康年会盛大召开。我们从本次会议的热点一窥行业创新升级的重点方向，关注抗体偶联药物、双特异性抗体、细胞与基因治疗等生物创新药领域的最新进展。2025JPM大会展示的ADC药物多达数十款，基本为第三代产品，面向肺癌、乳腺癌、肺癌等高发实体瘤，涌现出一大批创新前沿的生物技术公司。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250211140710abca815b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250211140710abca815b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["600276","603676","600380","688356","688505","BK0060","688566","BK0188","603811","603351","600062","600200","600513","603207","688799","BK0012","603168","600079","600196","603669","688176","600267","600521","BK0187","688578","BK0096","159992","688235","688302","603538","605177","603229","688117","688513","159760","600488","688658","BK0028","605116","BK0183","688690","688602","603520","688221","688247","688266","600774","688197","BK0239","600664","600420","603707","BK0196","605507","688373","600624","600216","688189","688553","603367","688321","688428","600613","688506","BK0175","601089"],"gpt_icon":0},{"id":"2510277958","title":"医药行业周报：诺华三抗新药PIT565在华再获批临床 用于SLE","url":"https://stock-news.laohu8.com/highlight/detail?id=2510277958","media":"太平洋证券股份...","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2510277958?lang=zh_cn&edition=full","pubTime":"2025-02-11 00:00","pubTimestamp":1739203200,"startTime":"0","endTime":"0","summary":"行业要闻：近日，中国国家药监局药品审评中心官网公示，诺华申报的1 类新药PIT565 获得一项新的临床试验默示许可，拟开发治疗系统性红斑狼疮。PIT565 是一款抗CD3/CD19/CD2 的三特异性抗体，可以靶向恶性B 细胞上的CD19，同时可与T 细胞上的CD3和CD2结合。与CD3 双特异性相比，通过PIT565共刺激CD2 可能会克服T 细胞衰竭，增加患者反应的深度和持续时间，该药此前在华获批针对B 细胞恶性肿瘤的IND。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250211120756961eb981&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250211120756961eb981&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["600774","688566","BK0060","688799","688212","603301","688189","600664","605507","603351","603987","688505","688767","688016","688382","600812","BK0188","603707","688617","603676","600276","600807","601089","688373","688091","600079","600200","688321","BK0028","688062","688026","688613","603309","600196","600380","688578","600587","603205","603387","688428","603207","603658","688576","603222","600789","603520","688580","688317","688607","605177","688198","688029","688602","688677","688690","600521","600267","688076","688606","600624","688298","688108","688235","688389","688581","688221","688067","688758","600420","688626","688217","605369","688575","688399","600613","688192","688273","600645","688151","600216","603538","688161","603229","688513","688050","688271","600055","603811","603168","603880","688166","688085","688139","603669","600529","BK0239","688266","603976","688358","688176","600062","688426","688302","688553","688075","600851","600488","688197","688506","688468","603367","688338","688117","688193","688356","605116","688013","600513","688247","688236","688658"],"gpt_icon":0},{"id":"2510880285","title":"威尔药业：公司高度重视股东回报，实行积极、稳健、持续的利润分配政策","url":"https://stock-news.laohu8.com/highlight/detail?id=2510880285","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2510880285?lang=zh_cn&edition=full","pubTime":"2025-02-10 16:00","pubTimestamp":1739174419,"startTime":"0","endTime":"0","summary":"公司高度重视股东回报，实行积极、稳健、持续的利润分配政策。近几年的现金分红金额均占到当年合并报表中归属于上市公司股东净利润的36%以上。未来公司将继续坚持在保证公司正常经营和长远健康发展的前提下，合理安排利润分配方案，积极回报投资者。2024年度利润分配方案拟与年度报告一并披露，届时敬请关注相关公告。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025021000018023.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603351","BK0275","BK0239"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1773041551236,"stockEarnings":[{"period":"1week","weight":-0.0264},{"period":"1month","weight":-0.0338},{"period":"3month","weight":-0.0123},{"period":"6month","weight":-0.0739},{"period":"1year","weight":0.0313},{"period":"ytd","weight":0.0211}],"compareEarnings":[{"period":"1week","weight":-0.0093},{"period":"1month","weight":0.0054},{"period":"3month","weight":0.0567},{"period":"6month","weight":0.0818},{"period":"1year","weight":0.2198},{"period":"ytd","weight":0.0391}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"南京威尔药业集团股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"6776人(较上一季度增加5.36%)","perCapita":"19988股","listingDate":"2019-01-30","address":"江苏省南京市六合区南京化学工业园区长丰河西路99号","registeredCapital":"13543万元","survey":"　　南京威尔药业集团股份有限公司的主营业务是药用辅料及合成润滑基础油产品的研发、生产和销售。公司的主要产品是药用辅料、合成润滑基础油。经江苏省经济和信息化委员会鉴定，公司聚山梨酯80（供注射用）产品“生产技术达到国际先进水平”，难燃液压液用酯类基础油、难燃液压液用水溶性高分子聚醚、高压乙烯压缩机油用醚类基础油等产品“生产技术达到国内领先水平”。","listedPrice":35.5},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"威尔药业(603351)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供威尔药业(603351)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"威尔药业,603351,威尔药业股票,威尔药业股票老虎,威尔药业股票老虎国际,威尔药业行情,威尔药业股票行情,威尔药业股价,威尔药业股市,威尔药业股票价格,威尔药业股票交易,威尔药业股票购买,威尔药业股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"威尔药业(603351)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供威尔药业(603351)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}